Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00014 | Mc-MMAF | 863971-19-1 |
| Mc-MMAF is a protective group-conjugated MMAF, MMAF is an antitubulin agent that inhibit cell division by blocking the polymerization of tubulin and it has lower cytotoxic activity than MMAE. | Inquiry | |
| BADC-00009 | DM1-SMCC | 1228105-51-8 |
| DM1 with a reactive linker SMCC, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR. | Inquiry | |
| BADC-00008 | Val-Cit-PAB-MMAE | 644981-35-1 |
| Val-Cit-PAB-MMAE, a tubulin polymerase inhibitor, is a drug-linker conjugate for ADC. It contains an ADC linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE. | Inquiry | |
| BADC-00010 | DM1-SPP | 452072-20-7 |
| DM1 with a reactive linker SPP, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR. | Inquiry | |
| BADC-00011 | DM4-SPDP | 2245698-48-8 |
| DM4 with a reactive linker SPDP, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. | Inquiry | |
| BADC-00012 | DM4-SPDB | 1626359-62-3 |
| DM4 with a reactive linker SPDB, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. | Inquiry | |
| BADC-00013 | MC-Val-Cit-PAB-MMAF | 863971-17-9 |
| MC-Val-Cit-PAB-MMAF is a potent tubulin inhibitor (MMAF), Val-Cit-PAB-MMAF is an antibody drug conjugate. | Inquiry | |
| BADC-00015 | MC-Val-Ala-PBD | 1342820-51-2 |
| MC-Val-Ala-PBD is a protective group conjugated PBD, PBD bind in the minor groove of DNA. | Inquiry | |
| BADC-00016 | Vat-Cit-PAB-MMAD | 1415329-13-3 |
| Vat-Cit-PAB-MMAD is a protective group conjugated MMAD, MMAD is a toxin payload in antibody drug conjugate. | Inquiry | |
| BADC-00017 | DM4-SMCC | 1228105-52-9 |
| DM4 with a reactive linker SMCC, which can react with antibody to make antibody drug conjugate. DM4 can bind to tubulin at or near the vinblastine-binding site. | Inquiry | |
| BADC-00021 | DM4-SMe | 796073-68-2 |
| DM4-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). . | Inquiry | |
| BADC-00022 | DM3-SMe | 796073-70-6 |
| DM3-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). . | Inquiry | |
| BADC-01449 | Pomalidomide-PEG3-CO2H | 2138440-82-9 |
| Pomalidomide-PEG3-C2-carboxylic acid is a PROTAC block consist of Pomalidomide linked to PEG with a carboxylic acid functional group for conjugation reactions. | Inquiry | |
| BADC-00629 | MC-Val-Cit-PAB-Auristatin E | 2055896-77-8 |
| MC-Val-Cit-PAB-Auristatin E is a drug-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker MC-Val-Cit-PAB. | Inquiry | |
| BADC-00802 | PAC | 2158322-33-7 |
| PAC is a PROTAC with an ADC linker, intended to be conjugated to an antibody. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). | Inquiry | |
| BADC-00803 | Cys-mcMMAD | |
| Cys-mcMMAD is a drug-linker conjugate for ADC. MMAD is a potent inhibitor of tubulin. | Inquiry | |
| BADC-00804 | DBCO-(PEG)3-VC-PAB-MMAE | |
| DBCO-(PEG)3-VC-PAB-MMAE is produced by MMAE conjugated to DBCO-(PEG)3-vc-PAB linker. Monomethyl auristatin E (MMAE) is a potent tubulin inhibitor. | Inquiry | |
| BADC-00805 | MAL-di-EG-Val-Cit-PAB-MMAE | |
| MAL-di-EG-Val-Cit-PAB-MMAE is a drug-linker conjugate containing the ADC linker MAL-di-EG-Val-Cit-PAB and the tubulin inhibitor MMAE. | Inquiry | |
| BADC-00806 | MAL-di-EG-Val-Cit-PAB-MMAF | |
| MAL-di-EG-Val-Cit-PAB-MMAF is a drug-linker conjugate containing the ADC linker MAL-di-EG-Val-Cit-PAB and the tubulin polymerization blocker MMAF. | Inquiry | |
| BADC-00807 | N3-PEG3-VC-PAB-MMAE | |
| N3-PEG3-VC-PAB-MMAE is a drug-linker conjugate containing the ADC linker N3-PEG3-VC-PAB and the tubulin inhibitor MMAE. | Inquiry |
